Outcome of surgical embolectomy in patients with massive pulmonary embolism with and without cardiopulmonary resuscitation

Hajizadeh, Reza; Ghaffari, Samad; Habibzadeh, Afshin; Safaei, Naser; Mohammadi, Kamran; Ranjbar, Abdolmohammad; Ghodratizadeh, Sahar

doi:10.5114/kitp.2017.72228

Cited by 2 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Park [16] reported a 14.8% surgical treatment mortality rate. Reza [6] recently reported 36 massive PE surgical treatments with 10 deaths and a mortality rate of 27.8%.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical outcomes of acute pulmonary embolectomy as the first-line treatment for massive and submassive pulmonary embolism: a single-centre study in China

Wang

Chen

Qiu

et al. 2020

J Cardiothorac Surg

View full text Add to dashboard Cite

Background Acute pulmonary embolism (PE) is one of the most critical cardiovascular diseases. PE treatment ranges from anticoagulation, and systemic thrombolysis to surgical embolectomy and catheter embolectomy. Surgical pulmonary embolectmy (SPE) indications and outcomes are still controversial. Although there have been more favourable SPE reports over the past decades, SPE has not yet been considered broadly as an initial PE therapy and is still considered as a reserve or rescue treatment for acute massive PE when systemic thrombolysis fails. This study aimed to evaluate the early and midterm outcomes of SPE, which was a first-line therapy for acute central major PE in one Chinese single centre. Methods A retrospective review of patients who underwent SPE for acute PE was conducted.Patients with chronic thrombus or who underwent thromboendarterectomy were excluded. SPE risk factors for morbidity and mortality were reviewed, and echocardiographic examination were conducted for follow-up studies to access right ventricular function. Results Overall, 41 patients were included; 17 (41.5%) had submassive PE, and 24 (58.5%) had massive PE. Mean cardiopulmonary bypass time was 103.2 ± 48.9 min, and 10 patients (24.4%) underwent procedures without aortic cross-clamping. Ventilatory support time was 78 h (range, 40–336 h), intensive care unit stay was 7 days (range, 3–13 days), and hospital stay was 16 days (range, 12–23 days). Operative mortalities occurred in 3 massive PE patients, and no mortality occurred in submassive PE patients. The overall SPE mortality rate was 7.31% (3/41). If two systemic thrombolysis cases were excluded, SPE mortality was low (2.56%,1/39), evenlthough there were 2 cases of cardiac arrest preoperatively. Patients’ right ventricle function improved postoperatively in follow-ups.There were no deaths related to recurrent PE and chronic pulmonary hypertension in follow-ups, though 3 patients died of cerebral intracranial bleeding, gastric cancer,and brain cancer at 1 year, 3 years, and 8 years postoperatively, respectively. Conclusions SPE presented with a low mortality rate when rendered as a first-line treatment in selected massive and submassive acute PE patients. Favorable outcomes of right ventricle function were also observed in the follow-ups. SPE should play the same role as ST in algorithmic acute PE treatment.

show abstract

“…Park [16] reported a 14.8% surgical treatment mortality rate. Reza [6] recently reported 36 massive PE surgical treatments with 10 deaths and a mortality rate of 27.8%.…”

Section: Discussionmentioning

confidence: 99%

“…Therefore, further research is needed to estimate the role of SPE in algorithmic PE treatment. Most studies were reported by authors from the USA, European countries, and from few developing countries [6]. The aim of this study is to assess the clinical outcomes of SPE for acute PE patients in a single cardiac centre in China.…”

Section: Introductionmentioning

confidence: 99%